Shares of Genfit SA (OTCMKTS:GNFTF) crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $5.09 and traded as low as $4.65. Genfit shares last traded at $4.65, with a volume of 510 shares changing hands.
The business’s 50 day simple moving average is $5.07 and its 200 day simple moving average is $4.94.
About Genfit (OTCMKTS:GNFTF)
Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, autoimmune, and fibrotic diseases affecting primarily the liver and gastroenterology. The company's lead products include Elafibranor, which is in pivotal Phase III clinical trials for the treatment of nonalcoholic steatohepatitis (NASH), as well as completed Phase II clinical trial to treat patients with primary biliary cholangitis; and Nitazoxanide that is in Phase II proof-of-concept clinical trial for the treatment of NASH-induced significant or severe fibrosis.
Featured Story: Net Income
Receive News & Ratings for Genfit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genfit and related companies with MarketBeat.com's FREE daily email newsletter.